We have reported the possible use of Thalidomide in multiple myeloma treatment before. Now it is definitely back with us.
Thalidomide, the drug banned around the world after causing some 11,000 birth defects and severe deformities in babies in the Sixties has been licensed for use as a cancer treatment in Australia.
Pharmion, a Colorado based company is expected to win approval to sell the drug again under its original name. After the Australian license is granted it will be a small further step for EU approval.
Thalidomide has been found to control the proliferation of cancer cells and prevent them sticking to bone marrow. Side effects are supposedly dry skin and dizziness, although the drug will not be allowed for use with pregnant women and prospective patients will have to sign a paper saying they understand the risks.